首页> 美国卫生研究院文献>Cells >The Nuclear Protein HOXB13 Enhances Methylmercury Toxicity by Inducing Oncostatin M and Promoting Its Binding to TNFR3 in Cultured Cells
【2h】

The Nuclear Protein HOXB13 Enhances Methylmercury Toxicity by Inducing Oncostatin M and Promoting Its Binding to TNFR3 in Cultured Cells

机译:核蛋白HOXB13通过诱导制瘤素M并促进其与培养细胞中TNFR3的结合增强甲基汞的毒性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Homeobox protein B13 (HOXB13), a transcription factor, is related to methylmercury toxicity; however, the downstream factors involved in enhancing methylmercury toxicity remain unknown. We performed microarray analysis to search for downstream factors whose expression is induced by methylmercury via HOXB13 in human embryonic kidney cells (HEK293), which are useful model cells for analyzing molecular mechanisms. Methylmercury induced the expression of oncostatin M (OSM), a cytokine of the interleukin-6 family, and this was markedly suppressed by HOXB13 knockdown. OSM knockdown also conferred resistance to methylmercury in HEK293 cells, and no added methylmercury resistance was observed when both HOXB13 and OSM were knocked down. Binding of HOXB13 to the OSM gene promoter was increased by methylmercury, indicating the involvement of HOXB13 in the enhancement of its toxicity. Because addition of recombinant OSM to the medium enhanced methylmercury toxicity in OSM-knockdown cells, extracellularly released OSM was believed to enhance methylmercury toxicity via membrane receptors. We discovered tumor necrosis factor receptor (TNF) receptor 3 (TNFR3) to be a potential candidate involved in the enhancement of methylmercury toxicity by OSM. This toxicity mechanism was also confirmed in mouse neuronal stem cells. We report, for the first time, that HOXB13 is involved in enhancement of methylmercury toxicity via OSM-expression induction and that the synthesized OSM causes cell death by binding to TNFR3 extracellularly.
机译:同源盒蛋白B13(HOXB13)是一种转录因子,与甲基汞毒性有关。但是,涉及增强甲基汞毒性的下游因素仍然未知。我们进行了微阵列分析以寻找下游因子,这些因子在人类胚胎肾细胞(HEK293)中是通过HOXB13的甲基汞诱导表达的,人类细胞是分析分子机制的有用模型细胞。甲基汞诱导白细胞介素6家族细胞因子癌抑素M(OSM)的表达,并被HOXB13抑制显着抑制。 OSM敲低还赋予HEK293细胞对甲基汞的抗性,而敲低HOXB13和OSM时未观察到增加的甲基汞抗性。甲基汞增加了HOXB13与OSM基因启动子的结合,表明HOXB13参与了其毒性的增强。因为向培养基中添加重组OSM可以增强在OSM击倒细胞中甲基汞的毒性,所以细胞外释放的OSM被认为可以通过膜受体增强甲基汞的毒性。我们发现肿瘤坏死因子受体(TNF)受体3(TNFR3)是参与OSM增强甲基汞毒性的潜在候选人。在小鼠神经元干细胞中也证实了这种毒性机制。我们首次报告,HOXB13通过OSM表达诱导参与增强甲基汞毒性,并且合成的OSM通过与细胞外结合TNFR3引起细胞死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号